Empowering Arkansas entrepreneurs in healthcare and health tech. Receive comprehensive support and networking opportunities to accelerate your venture. Apply now to join the 2024 cohort and shape the future of healthcare entrepreneurship.
Make a difference by developing technology-driven solutions to enhance healthcare infrastructure, expand access to prenatal and postnatal care, and empower women with the tools they need for better health outcomes.
The present disclosure provides SL and SL derivatives comprising a polar substituent adjacent to the lactone ring. Additionally, the present disclosure provides methods of using the SL and SL derivatives to inhibit the growth of leukemic cancer cells.
Novel alkylindoles that bind tightly to cannabinoid receptors and are neutral antagonists for the cannabinoid 1 receptor and agonists for the cannabinoid 2 receptor are provided. These compounds are useful for treating alcoholism and drug abuse and for treating obesity.
Use of DNA-PKcs inhibitors to reduce immune response in a subject or reduce the risk of graft rejection in a transplant patient
BioVentures was established as a formal outgrowth of the University of Arkansas for Medical Sciences‘ (UAMS) interest in promoting a biomedical technology industry for Arkansas and translating its research into products that benefit human health.
UAMS established BioVentures to maximize global, industrial interaction with the University of Arkansas faculty, as well as to facilitate technology transfer, the development of startup companies that are based on technology developed at UAMS, and contributions to Arkansas’ economic development.
BioVentures links the research minds at UAMS to global markets in order to advance Arkansas’ scientific and economic development.
Medicine is changing rapidly in the face of technology and innovation. Today’s medical students must not only keep up with these changes, they should be
The AR Health Ventures Accelerator (ARHVA) invites UAMS employees to submit innovative therapeutic or drug discovery ideas for significant financial and administrative support toward commercialization.
The Health Sciences Innovation and Entrepreneurship (HSIE) Training Program has been awarded a $952,975 grant over five years to continue its pioneering work teaching postdoctoral fellows at UAMS how to commercialize their discoveries.
401 South Cedar Street Little Rock, Arkansas 72205
(501) 686-6696
bioventures@uams.edu
